Skip to content

Clinical trials

Stroke trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Country / region: Germany Clear all

335 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20023
20035
20045
200513
200612
20078
200815
200920
201014
201118
201216
201320
201418
201514
201616
201716
201817
201920
202013
202113
20228
202310
202410
202514
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed199
Unknown status48
Recruiting34
Terminated31
Active, not recruiting11
Not yet recruiting5
Suspended4
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Charite University, Berlin, Germany35
Universitätsklinikum Hamburg-Eppendorf18
Bayer10
University Hospital Muenster9
Boston Scientific Corporation8
University of Giessen8
Insel Gruppe AG, University Hospital Bern7
Ludwig-Maximilians - University of Munich7
University Hospital Heidelberg7
University Hospital Tuebingen7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke335
Ischemic Stroke69
Atrial Fibrillation46
Ischemic Attack, Transient26
Myocardial Infarction20
Cerebrovascular Disorders18
Ischemia16
Cardiovascular Diseases13
Aphasia10
Hemorrhage10

Trials

Showing 76 to 100 of 335. Each trial links to its page on Pharma Observatory.

235 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.